Also trades as: CALZF (OTC) · $vol 0M
PNV.AX ASX
PolyNovo Limited
1W: -1.7%
1M: +12.9%
3M: +14.0%
YTD: +14.0%
1Y: +1.8%
3Y: -30.5%
5Y: -62.6%
A$1.13 ($0.81)
-0.01 (-0.44%)
Weekly Expected Move ±9.6%
A$1
A$1
A$1
A$1
A$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapA$784.1M ($559.0M)
52W Range0.865-1.665
Volume3,091,892
Avg Volume2,389,231
Beta1.27
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBruce Peatey
Employees282
SectorHealthcare
IndustryMedical - Devices
IPO Date1998-11-30
Websitepolynovo.com
320 Lorimer Street
Port Melbourne, VIC 3207
AU
Port Melbourne, VIC 3207
AU
61 3 8681 4050
About PolyNovo Limited
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Latest News
No recent news
Recent Insider Trades
No insider trades found